Archives
-
Cy5-UTP for RNA Probes and Condensate Assays
2026-08-17
Cy5-UTP enables direct, far-red visualization of RNA made by T7 RNA polymerase, connecting routine probe synthesis with FISH, dual-color expression arrays, and RNA–protein condensate studies. This workflow-focused guide explains how to control labeling density, preserve RNA quality, and translate fluorescent U3 snoRNA findings into practical assay designs.
-
3X FLAG Peptide for Mechanism-Aware Assays
2026-08-17
The 3X (DYKDDDDK) Peptide is more than a detection reagent: it can help separate protein abundance, localization, interaction, and function in complex assays. This guide connects FLAG-tag workflow design with insights from CTDNEP1–NEP1R1 research, emphasizing controls, metal sensitivity, and structural biology.
-
Dorsomorphin 2HCl: AMPK Assay Guide
2026-08-16
A scenario-based guide to using Dorsomorphin 2HCl (SKU B1372) in cell viability, proliferation, cytotoxicity, AMPK, and BMP pathway experiments. It connects formulation, controls, interpretation, and vendor-selection decisions to product specifications and published AMPK evidence.
-
3X (DYKDDDDK) Peptide: Assay Design Guide
2026-08-15
Learn how the 3X (DYKDDDDK) Peptide can strengthen recombinant protein validation, affinity workflows, and structural studies. This guide connects 3X FLAG assay design with new lessons from micropeptide research in hepatocellular carcinoma.
-
3X FLAG Peptide for Chromatin Assays
2026-08-14
The 3X (DYKDDDDK) Peptide can strengthen recombinant protein purification and detection while preserving a rigorous approach to chromatin biochemistry. Learn how to use 3X FLAG peptide workflows for PRC2 assays, metal-sensitive readouts, and structural studies without confusing tag behavior with molecular mechanism.
-
Trelagliptin, RUNX2, and Osteoblast Differentiation
2026-08-14
The reference study shows that Trelagliptin enhances osteoblastic differentiation and mineralization in MC3T3-E1 cells while increasing RUNX2, ALP, osteocalcin, osteopontin, and BMP-2. Its use of AMPK blockade links the phenotype to AMPK activation, although the findings remain preclinical and do not establish Trelagliptin as an osteoporosis treatment.
-
Antibiotic Use and Resistance in Psychiatric Hospitals
2026-08-13
This retrospective study links antibacterial-drug utilization with bacterial resistance patterns in a psychiatric hospital during the 2022 epidemic. Its main contribution is a hospital-specific stewardship framework combining consumption metrics, microbiological submission, pathogen identification, and susceptibility testing to guide more defensible antibiotic decisions.
-
Arachidonic Acid Supplementation and Humoral Immunity
2026-08-13
The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node pathway in which an arachidonic acid metabolite, prostaglandin I2, signals through cAMP–PKA to enhance CD86 expression and activation-induced cytidine deaminase in B cells.
-
Amitriptyline HCl: Applied Assay Workflow
2026-08-12
A practical guide to using Amitriptyline HCl in receptor, signaling, and exploratory host–virus assays. The workflow combines concentration-aware pharmacology with lipidomics-informed controls inspired by recent RGNNV research, while clearly separating established product properties from investigational cross-domain applications.
-
Selonsertib (GS-4997): A Renal Assay Playbook
2026-08-12
Selonsertib (GS-4997) is an ASK1-selective research tool for connecting oxidative stress, MAPK signaling, tubular injury, inflammation, and fibrosis. This renal-focused guide translates lupus nephritis findings into practical assay design and interpretation decisions.
-
BR101801 and Venetoclax in Double-Hit DLBCL
2026-08-11
This 2023 study reports that BR101801 potentiates Venetoclax in double-hit diffuse large B-cell lymphoma by jointly suppressing c-Myc, Bcl-2, and Mcl-1. The combination increased apoptotic signaling and produced stronger tumor control than either agent alone, including in a late xenograft model, supporting multitarget strategies for resistant DLBCL.
-
MTT Assays: From Metabolism to HCC Mechanism
2026-08-11
A mechanism-aware guide to using MTT as a metabolic phenotype readout in hepatocellular carcinoma research, with practical controls, interpretation strategies, and translational decision points anchored to miR-519d, Rab10, and AMPK signaling.
-
Heparin Sodium as a Mechanistic Probe in Exosome Research
2026-08-10
Heparin sodium can do more than control coagulation: it can help translational teams interrogate heparan sulfate proteoglycan-dependent uptake. Paired with findings from a Cistanche deserticola nanovesicle study, this strategy connects anti-factor Xa and aPTT quality control with mechanistic validation while preserving clear limits around clinical interpretation.
-
L-Alanyl-L-Glutamine: Practical Lab Workflow
2026-08-09
L-Alanyl-L-Glutamine (SKU B8228) is a water-soluble L-Ala-L-Gln dipeptide for controlled nutritional, gastrointestinal, and aqueous research workflows. It is appropriate when a stable glutamine-containing supplement is needed, but not for DMSO- or ethanol-based preparation or long-term storage of solutions.
-
Chlorambucil Assays: From DNA Damage to Cell Death
2026-08-08
Build more informative Chlorambucil experiments by separating growth inhibition from true cell killing. This workflow combines DNA-damage biology, time-resolved viability measurements, and practical troubleshooting for CLL, glioma, and other cancer cell models.